Home » Stocks » Aytu BioScience

Aytu BioScience, Inc. (AYTU)

Stock Price: $1.37 USD -0.04 (-2.84%)
Updated Jul 2, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 165.24M
Revenue (ttm) 14.49M
Net Income (ttm) -25.01M
Shares Out 120.62M
EPS (ttm) -0.25
PE Ratio n/a
Forward PE 11.61
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Jul 2, 2020
Last Price $1.37
Previous Close $1.41
Change ($) -0.04
Change (%) -2.84%
Day's Open 1.40
Day's Range 1.31 - 1.42
Day's Volume 7,788,659
52-Week Range 0.34 - 2.99

More Stats

Market Cap 165.24M
Enterprise Value 107.44M
Earnings Date (est) Aug 27, 2020
Ex-Dividend Date n/a
Shares Outstanding 120.62M
Float 116.08M
EPS (basic) -1.78
EPS (diluted) -0.25
FCF / Share -0.68
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 9.95M
Short Ratio 0.82
Short % of Float 8.79%
Beta 0.25
PE Ratio n/a
Forward PE 11.61
P/FCF Ratio n/a
PS Ratio 11.41
PB Ratio 2.13
Revenue 14.49M
Operating Income -19.08M
Net Income -25.01M
Free Cash Flow -24.08M
Net Cash 57.80M
Net Cash / Share 0.48
Gross Margin 35.33%
Operating Margin -131.68%
Profit Margin -172.60%
FCF Margin -166.24%
ROA -12.09%
ROE -49.16%
ROIC 502.20%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (2)

Buy 2
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(100.73% upside)
Current: 1.37
Target: 2.75
*Average 12-month price target from 2 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth100%13.61%25.72%878.85%344.23%-
Gross Profit5.121.611.801.610.170.06
Operating Income-16.85-19.70-20.13-21.70-7.63-6.35
Net Income-27.13-10.19-22.51-28.18-7.72-5.58
Shares Outstanding7.790.670.47---
Earnings Per Share-3.48-15.31-48.30-6,474.00-4,028.00-3,840.15
Operating Cash Flow-13.83-15.94-13.83-10.66-6.63-5.50
Capital Expenditures-0.06-0.07-0.11-0.25--0.01
Free Cash Flow-13.89-16.02-13.94-10.91-6.63-5.51
Cash & Equivalents11.297.110.889.107.362.64
Total Debt---5.38-4.60
Net Cash / Debt11.297.110.883.727.36-1.96
Book Value7.0913.424.0010.0915.625.37
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Aytu BioScience, Inc.
Country United States
Employees 61
CEO Joshua R. Disbrow

Stock Information

Ticker Symbol AYTU
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: AYTU


Aytu BioScience, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel products in the field of hypogonadism (low testosterone), cough and upper respiratory symptoms, insomnia, and male infertility in the United States and internationally. The company markets Natesto, a nasal gel for the treatment of hypogonadism (low testosterone) in men; and Tuzistra XR, a prescription antitussive consisting of codeine polistirex and chlorpheniramine polistirex in an oral suspension. It also offers ZolpiMist, an oral spray for the treatment of insomnia; and MiOXSYS, an in vitro diagnostic semen analysis test that is used in the measurement of static oxidation reduction potential in human semen. Aytu BioScience, Inc. is based in Englewood, Colorado.